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Introduction
Early diagnosis of sepsis is the key for improving the
survival, therefore biomarkers have an important place
in this process because they can indicate the presence
or absence of sepsis [1]. Procalcitonin aids in diagnosis
and risk stratification of bacterial sepsis [2].Using
pro-BNP as inflammatory marker in diagnosing severe
sepsis and septic shock is based on cytokines produc-
tion independent of myocardial dysfunction. Bacterial
endotoxins secreted from Gram-negative organisms
and Staphylococcus aureus alpha toxin increase the
BNP messenger RNA expression. Also the activity of
Neutral endopeptidase 24.11 the enzyme responsible
for degradation of proBNP decreases in septic shock.
Finally, proBNP clearance decreases due to renal dys-
function [3].
Objectives
In this study we compared the diagnostic value of
ProBNP and procalcitonin in severe sepsis patients.
Methods
24 patients with the preliminary diagnosis of severe sep-
sis were divided into two groups according to Echocar-
diography (Echo) findings, cultures from suspected sites
of infection were done. Blood levels of CRP, ProBNP
and PCT were measured on admission. We compared
ProBNP and PCT levels in severe sepsis patients with
normal Echo findings and those with systolic and/or
diastolic dysfunction and we also compared level of
ProBNP in these two groups with the control group.
Results
Level of proBNP was very high in total patients com-
pared to control group. Level of proBNP to diagnose
severe sepsis in patients group (with cutoff point
>108pg/ml as recommended by Youden’s index) had
95.83% sensitivity, 83.33% specificity with 92.0% PPV,
90.91% NPV and 91.67% accuracy.To differentiate severe
sepsis patients with normal Echo findings from those
with abnormal Echo findings, ProBNP (with cutoff point
>2900 pg/ml) had 41.67% sensitivity, 83.33% specificity,
71.43% PPV, and 58.82% NPV with 62.50% accuracy and
PCT (with cutoff point >2 pg/ml) had 66.67% sensitivity,
50.0% specificity, 57.14% PPV, 60% NPV with 58.33%
accuracy.
Conclusions
ProBNP level increased in all patients with severe sepsis
and septic shock with or without cardiac dysfunction, so
ProBNP might be a good marker for severe sepsis.
ProBNP level was a good marker for systolic dysfunction
but ProBNP or PCT levels could not differentiate
between severe sepsis patients with or without cardiac
dysfunction.
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